Form 483

Sher Fertility Solutions New York Form 483, 2025-07-22

FDA issued a Form 483 to Sher Fertility Solutions New York on 2025-07-22 with 4 public-safe observations.

483· Form 483 issuedBiologics4 observations

Sher Fertility Solutions New York · New York, United States · Issued July 22, 2025

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

22 Jul 2025
21 CFR 1271.55(b)(4)

Reasons for ineligibility on summary

Cited by Irina Gaberman

22 Jul 2025
21 CFR 1271.55(d)(2)

Accurate, indelible, legible

Cited by Irina Gaberman

22 Jul 2025
21 CFR 1271.75(b)

Risk factors, leukocyte-rich cells or tissues

Cited by Irina Gaberman

22 Jul 2025
21 CFR 1271.90(c)

Eligibility not required--warning labels

Cited by Irina Gaberman

Inspected site

SFSher Fertility Solutions New YorkNew York, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 1271.55(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 1271.55(d)(2)Cited across public-safe Form 483 observations1x
21 CFR 1271.75(b)Cited across public-safe Form 483 observations1x
21 CFR 1271.90(c)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 4 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere